Korsana Biosciences, Inc.
Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: KRSA
Korsana Biosciences, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker KRSA. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2023.
Korsana Biosciences at a glance
What does Korsana Biosciences do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $5 million sold (2023).
Frequently asked questions about Korsana Biosciences
Where is Korsana Biosciences headquartered?
Korsana Biosciences, Inc. is headquartered in Waltham, Massachusetts, United States.
What does Korsana Biosciences do?
Korsana Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Korsana Biosciences a public company?
Yes. Korsana Biosciences, Inc. trades on Nasdaq under the ticker KRSA.
When was Korsana Biosciences founded?
The earliest incorporation on record for Korsana Biosciences, Inc. is in 2018, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
- Werewolf Therapeutics, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.